Journal of Inflammation Research
Volume 16, 2023 - Issue
Open access
260
Views
3
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH
Synergistic Enhancement of Isoforskolin and Dexamethasone Against Sepsis and Acute Lung Injury Mouse Models
Yan Fang1 School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, People’s Republic of China;2 The First Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China
, Chuang Xiao1 School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, People’s Republic of China
, Lueli Wang1 School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, People’s Republic of China
, Youlan Wang3 Kunming Institute of Medical Sciences, Kunming, People’s Republic of China
, Jun Zeng1 School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, People’s Republic of China
, Yaping Liang1 School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, People’s Republic of China
, Rong Huang1 School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, People’s Republic of China
, Yunke Shi2 The First Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China
, Sha Wu1 School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, People’s Republic of China
, Xiaohua Du2 The First Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China
, Shibo Sun2 The First Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China
, Min Li2 The First Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China
, Yuanyuan Zheng2 The First Affiliated Hospital of Kunming Medical University, Kunming, People’s Republic of China
, Hongxiang Wu1 School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, People’s Republic of China
, Qiuzhe Guo4 Fuwai Yunnan Cardiovascular Hospital, Kunming, People’s Republic of ChinaCorrespondence[email protected] [email protected]
& Weimin Yang1 School of Pharmaceutical Science and Yunnan Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, People’s Republic of China
show all
Pages 5989-6001
|
Received 14 May 2023, Accepted 09 Oct 2023, Published online: 07 Dec 2023
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.